Consistent with the most recent of previous study (Burns et al., 2020), we hypothesise that depression symptom scores will increase across later-life and that APOE e4 carriers will experience a significantly greater increase than non-e4 carriers, independently of covariates such as sex and childhood cognitive ability. This evidence concerns the gene APOE and depressive symptom measurement.